Previous 10 | Next 10 |
home / stock / allgf / allgf news
LUND, Sweden , June 1, 2020 /PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX), today announces that the company received an additional USD 0.5 million in a second installment of the upfront payment from the Chinese company Biotheus Inc. A first installment of USD 0.5 mil...
STOCKHOLM , April 23, 2020 /PRNewswire/ -- Stronger focus on clinical projects "The focusing of our operations protects the company's liquidity, but is also part of our long-term strategy with a emphasis on clinical projects and innovation," CEO Per Norlén comments. Signifi...
LUND, Sweden , April 20, 2020 /PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX), today announced that the company's Nomination Committee, following an initiative from all members of the Board of Directors, proposes that the fees to board-members are reduced with 20 percent ...
LUND, Sweden , April 7, 2020 /PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX) , announced today that the company has decided to increase its focus on the clinical development portfolio. In order to secure value for its clinical drug candidates, Alligator will reduce invest...
STOCKHOLM , March 31, 2020 /PRNewswire/ -- The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedish text shall prevail. The shareholders of Alligator Bioscience AB, Reg. No. 556597-8201, are invited t...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...
LUND, Sweden , Nov. 29, 2019 /PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced that the company has appointed Dr Malin Carlsson as Chief Operating Officer. She most recently comes from a position as Vice President, Head of Translational Medicine ...
LUND, Sweden , Nov. 6, 2019 /PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX), today announced that the company will present new preclinical data showing that their drug candidate ATOR-1017 can induce a long-lasting immunological memory which is of great importance in a pot...
Alligator Bioscience ( OTC:ALLGF ): Q3 GAAP EPS of -SEK0.79. More news on: ALLIGATOR BIOSCIENCE AB, Earnings news and commentary, , Read more ...
STOCKHOLM , Oct. 24, 2019 /PRNewswire/ -- " We are now regaining the exclusive, global rights to develop and commercialize ADC-1013 and at the same time receive enough ADC-1013 substance to, with or without a new partner, bring ADC-1013 into Phase II clinical trials next year. In total, w...
News, Short Squeeze, Breakout and More Instantly...
Alligator Bioscience AB Company Name:
ALLGF Stock Symbol:
OTCMKTS Market:
Alligator Bioscience recruits new Chief Medical Officer PR Newswire LUND, Sweden , Dec. 29, 2020 /PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced that the company has appointed Dr Christina Reimer as Chief Medical Officer. Sh...
Alligator Bioscience submits CTA for the mitazalimab Phase II study OPTIMIZE-1 PR Newswire LUND, Sweden , Dec. 28, 2020 /PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced that it has submitted a CTA (Clinical Trial Authorization) a...
Alligator Bioscience launches ALLIGATOR-FAB™ - a novel human antibody library LUND, Sweden , Dec. 10, 2020 /PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced the completion of a novel proprietary human synthetic antibody librar...